John G. Edwards
Chief Executive Officer at Drusolv Therapeutics, Inc.
John G. Edwards active positions
| Companies | Position | Start | End |
|---|---|---|---|
Drusolv Therapeutics, Inc.
 Drusolv Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Drusolv Therapeutics, Inc. is an American clinical-stage drug company that is developing a high-dose statin for early intervention in age-related macular degeneration. The CEO of the company is John G. Edwards. | Director/Board Member | - | - |
| Chief Executive Officer | - | - |
Career history of John G. Edwards
Statistics
International
| United States | 2 |
Operational
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Drusolv Therapeutics, Inc.
Drusolv Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Drusolv Therapeutics, Inc. is an American clinical-stage drug company that is developing a high-dose statin for early intervention in age-related macular degeneration. The CEO of the company is John G. Edwards. | Commercial Services |
- Stock Market
- Insiders
- John G. Edwards
- Experience
